Quick Takeaways
- James E. Flynn filed SCHEDULE 13D/A for Larimar Therapeutics, Inc. Common Stock, par value $0.0001 per share (LRMR).
- Disclosed ownership: 36%.
- Date of event: 31 Jul 2025.
Quoteable Key Fact
"James E. Flynn disclosed 36% ownership in Larimar Therapeutics, Inc. Common Stock, par value $0.0001 per share (LRMR) on 31 Jul 2025."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Deerfield Private Design Fund III, L.P. | 11% | 9,538,918 | 0 | 9,538,918 | /s/ Jonathan Isler | Jonathan Isler, Attorney-in-Fact | 0001603333 |
| Deerfield Healthcare Innovations Fund, L.P. | 8.6% | 7,321,129 | 0 | 7,321,129 | /s/ Jonathan Isler | Jonathan Isler, Attorney-in-Fact | 0001646981 |
| Deerfield Private Design Fund IV, L.P. | 11% | 9,538,945 | 0 | 9,538,945 | /s/ Jonathan Isler | Jonathan Isler, Attorney-in-Fact | 0001680307 |
| Deerfield Partners, L.P. | 4.9% | 4,207,982 | 0 | 4,207,982 | /s/ Jonathan Isler | Jonathan Isler, Attorney-in-Fact | 0001301041 |
| Deerfield Mgmt III, L.P. | 11% | 9,538,918 | 0 | 9,538,918 | /s/ Jonathan Isler | Jonathan Isler, Attorney-in-Fact | 0001610540 |
| Deerfield Mgmt HIF, L.P. | 8.6% | 7,321,129 | 0 | 7,321,129 | /s/ Jonathan Isler | Jonathan Isler, Attorney-in-Fact | 0001665736 |
| Deerfield Mgmt IV, L.P. | 11% | 9,538,945 | 0 | 9,538,945 | /s/ Jonathan Isler | Jonathan Isler, Attorney-in-Fact | 0001713467 |
| Deerfield Mgmt, L.P. | 4.9% | 4,207,982 | 0 | 4,207,982 | /s/ Jonathan Isler | Jonathan Isler, Attorney-in-Fact | 0001010823 |
| Deerfield Management Company, L.P. | 36% | 30,667,474 | 0 | 30,667,474 | /s/ Jonathan Isler | Jonathan Isler, Attorney-in-Fact | 0001009258 |
| James E. Flynn | 36% | 30,667,474 | 0 | 30,667,474 | /s/ Jonathan Isler | Jonathan Isler, Attorney-in-Fact | 0001352546 |